Managing Dermal Lesions with HBOT
Skin or dermal lesions can vary in color or texture and can either present at birth or develop during the person’s lifetime. Lesions can be associated with infectious diseases such as warts, acne, psoriasis or allergic reactions. Dermal lesions are also the product of common environmental agents like sunburn and temperature extremes.
HBOT has been used successfully in a wide array of dermal lesions associated with skin disorders, which include:
- Skin grafting
- Skin ulcers
- Skin infections
- Chronic Diabetic skin lesions such infected or ischemic ulcers and Necrobiosis Lipoidica Diabeticorum
- Pyoderma Gangrenosum
- Purpura Fulminans
- Toxic Epidermal Necrolysis
- Sclerodermatous skin lesions (secondary to Raynaud’s phenomenon)
The logical reasons for its use include the activation of dermal metabolism, the antibacterial effect, and possibly an immunosuppressive effect.
The utility of HBOT in dermal lesions is largely due to increased delivery of oxygen to the skin resulting in more efficient and rapid healing, and in the case of infections the supply of oxygen where anaerobic organisms are responsible, decreasing the favorable environment of growth. The increased oxygen also aids the more efficient function of antibiotics.
Certain skin lesions that have an underlying decreased vascular component, such as lesions seen in diabetics, are aided in their healing with a better supply of oxygen.
- George Allibone M.D.